Recording · February 2026
ATP Confirmation and You
What Authorized Trading Partner confirmation actually requires, with Abha Kundi, who developed and directed FDA’s DSCSA program, now at ArentFox Schiff.
Abha KundiCounsel, ArentFox SchiffFormer FDA DSCSA leadProfile →
Alex ColganLedgerDomain
What the session covers
- Current DSCSA requirements and where enforcement is actually landing
- Lessons from FDA’s first DSCSA 483 issued to a dispenser
- How to document ATP confirmation as real “evidence of review”
- Why spreadsheets and shared folders no longer survive scrutiny
- A practical compliance action plan you can start this quarter
Questions about your own ATP position?
Pick a time and we will walk through it against your actual trading partner list.
More sessions with regulatory and compliance leaders
Oct 2024DSCSA Exemptions and You!With special guest Tish PahlWatch →Sep 2024Tying Up the Loose Ends for DSCSAWith Rx Supply Chain AdvisorsWatch →Jul 2024DSCSA Industry Status and Roadmap to NovemberWith Rx Supply Chain AdvisorsWatch →Jun 2024Unlocking the Value of DSCSA with Credentials and Customer Master DataWith IQVIAWatch →
